Surmodics Inventory Turnover Ratio 2006-2019 | SRDX
Surmodics inventory turnover ratio from 2006 to 2019. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period.
| Surmodics Inventory Turnover Ratio Historical Data | |||
|---|---|---|---|
| Date | |||
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.533B | $0.100B |
| SurModics, Inc. is a leading provider of surface modification technologies in the areas of biocompatibility, site specific drug delivery, biological cell encapsulation, and medical diagnostics. SurModics partners with the world's foremost medical device, pharmaceutical and life science companies to bring innovation together for better patient outcomes. Recent collaborative efforts include the implementation of SurModics' Bravo drug delivery polymer matrix as a key component of the first-to-market drug-eluting coronary stent. SurModics is also active in the ophthalmology market with a sustained drug delivery system that is currently in human trials for treatment of retinal disease. A significant portion of SurModics' revenue is generated by royalties earned from the sale of our customers' commercial products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $149.261B | 20.95 |
| Abbott Laboratories (ABT) | United States | $149.010B | 27.18 |
| Stryker (SYK) | United States | $76.714B | 25.79 |
| Boston Scientific (BSX) | United States | $58.945B | 27.82 |
| Baxter (BAX) | United States | $41.416B | 25.11 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $33.904B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $29.822B | 18.71 |
| Terumo (TRUMY) | Japan | $26.925B | 33.60 |
| Coloplast (CLPBY) | Denmark | $25.499B | 40.71 |
| Lonza Group Ag (LZAGY) | Switzerland | $25.289B | 0.00 |
| ResMed (RMD) | United States | $21.249B | 39.20 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $19.012B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $17.210B | 0.00 |
| Insulet (PODD) | United States | $11.282B | 536.73 |
| Bio-Rad Laboratories (BIO) | United States | $10.725B | 51.48 |
| Hill-Rom Holdings (HRC) | United States | $6.983B | 20.59 |
| Perrigo (PRGO) | Ireland | $6.665B | 12.43 |
| William Demant Holdings (WILYY) | Denmark | $6.665B | 0.00 |
| DiaSorin S.p.A (DSRLF) | Italy | $6.420B | 0.00 |
| Haemonetics (HAE) | United States | $6.037B | 40.79 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $5.382B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $5.276B | 27.26 |
| Canopy Growth (CGC) | Canada | $4.955B | 0.00 |
| NuVasive (NUVA) | United States | $3.778B | 29.75 |
| ICU Medical (ICUI) | United States | $3.688B | 24.04 |
| Neogen (NEOG) | United States | $3.350B | 56.05 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.165B | 0.00 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.147B | 0.00 |
| Quidel (QDEL) | United States | $2.687B | 25.50 |
| Aurora Cannabis (ACB) | Canada | $2.346B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.162B | 48.80 |
| Agios Pharmaceuticals (AGIO) | United States | $2.128B | 0.00 |
| InMode (INMD) | Israel | $1.670B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.522B | 0.00 |
| AtriCure (ATRC) | United States | $1.126B | 0.00 |
| VAREX IMAGING (VREX) | United States | $1.125B | 22.54 |
| Aphria (APHA) | $0.961B | 0.00 | |
| Phibro Animal Health (PAHC) | United States | $0.923B | 17.28 |
| NanoString Technologies (NSTG) | United States | $0.838B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.825B | 20.62 |
| TG Therapeutics (TGTX) | United States | $0.790B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.777B | 29.75 |
| LeMaitre Vascular (LMAT) | United States | $0.685B | 38.49 |
| Omeros (OMER) | United States | $0.661B | 0.00 |
| PetIQ (PETQ) | United States | $0.655B | 15.99 |
| Quanterix (QTRX) | United States | $0.628B | 0.00 |
| Cerus (CERS) | United States | $0.613B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.484B | 29.04 |
| Owens & Minor (OMI) | United States | $0.419B | 15.51 |
| MacroGenics (MGNX) | United States | $0.413B | 0.00 |
| HEXO (HEXO) | $0.409B | 0.00 | |
| Utah Medical Products (UTMD) | United States | $0.378B | 27.36 |
| Meridian Bioscience (VIVO) | United States | $0.374B | 12.88 |
| Organigram Holdings (OGI) | Canada | $0.322B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.302B | 123.08 |
| Zynex (ZYXI) | United States | $0.299B | 33.81 |
| Vapotherm (VAPO) | United States | $0.244B | 0.00 |
| United Health Products (UEEC) | United States | $0.240B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.239B | 0.00 |
| Bovie Medical (APYX) | United States | $0.239B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.233B | 0.00 |
| Repro-Med Systems (KRMD) | United States | $0.164B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.146B | 734.00 |
| Cytosorbents (CTSO) | United States | $0.133B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.131B | 0.00 |
| Fonar (FONR) | United States | $0.130B | 9.18 |
| Liberty Health Sciences (LHSIF) | Canada | $0.124B | 0.00 |
| Female Health (VERU) | United States | $0.123B | 0.00 |
| Chimerix (CMRX) | United States | $0.122B | 0.00 |
| United-Guardian (UG) | United States | $0.088B | 22.24 |
| Chembio Diagnostics (CEMI) | United States | $0.079B | 0.00 |
| Nephros (NEPH) | United States | $0.064B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.057B | 0.00 |
| MRI Interventions (MRIC) | United States | $0.056B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.046B | 0.00 |
| Surface Oncology (SURF) | United States | $0.045B | 0.00 |
| ImmuCell (ICCC) | United States | $0.037B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.024B | 0.00 |
| Senestech (SNES) | United States | $0.018B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.015B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.013B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.011B | 0.00 |
| Myomo (MYO) | United States | $0.009B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.008B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.003B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.003B | 0.00 |
